AKER
Akers Biosciences Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| 03-31-2019 | 03-31-2019 | 03-31-2019 | 11-15-2018 | 08-14-2018 | 07-13-2018 | 04-03-2018 | 11-15-2017 | 08-14-2017 after market close | 05-16-2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Actual EPS | -0.34 | -0.34 | -0.34 | -0.26 | -0.02 | -0.03 | -0.23 | -0.13 | -0.08 | -0.19 |
| Consensus EPS | ||||||||||
| Estimated EPS | ||||||||||
| Number of Estimates | ||||||||||
| EPS Surprise |
Stats
Summary
Akers Biosciences Inc is engaged in the development and sale of disposable diagnostic testing device. The Company develops, manufactures, and supplies rapid, point-of-care screening and testing products.
Market Cap: 7.47 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.akersbio.com
Shares Outstanding: 31.4 Million
Float: 30.6 Million
Dividend: 0.0 (0.0%)
Beta: -126.154984
Sector: Healthcare
Industry: Medical Instruments & Equipment
Short Interest (Jan 12, 2018): 918 Thousand
Ethical Flags
Longest drawdown: 1599 trading days
From: 2013-10-21 To: 2019-04-18
Lowest Point:
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2019-04-01 13:37:47:000
Akers Biosciences (NASDAQ: AKER ): FY GAAP EPS of -$0.99. More news on: Akers Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Thin ranks in premarket gainers
via: SeekingAlpha at 2018-11-20 09:15:27:000
Bioblast Pharma ORPN +22% on acquisition of Enlivex Therapeutics in all-stock deal. More news on: Akers Biosciences Inc., Stocks on the move, , Top stock market news, Read more … read more...
Thin ranks in premarket gainers
via: SeekingAlpha at 2018-11-20 09:15:27:000
Bioblast Pharma ORPN +22% on acquisition of Enlivex Therapeutics in all-stock deal. More news on: Akers Biosciences Inc., Stocks on the move, , Top stock market news, Read more … read more...
Thin ranks in premarket gainers
via: SeekingAlpha at 2018-11-20 09:15:27:000
Bioblast Pharma ORPN +22% on acquisition of Enlivex Therapeutics in all-stock deal. More news on: Akers Biosciences Inc., Stocks on the move, , Top stock market news, Read more … read more...
Microcaps dominate midday movers
via: SeekingAlpha at 2018-11-19 12:52:48:000
Mesa Air Group, Inc. (NASDAQ: MESA ) -14% . More news on: Akers Biosciences Inc., Yulong Eco-Materials, Leju Holdings Limited, Stocks on the move, , Read more … read more...
AKER, LEJU among premarket gainers
via: SeekingAlpha at 2018-11-19 09:16:33:000
Akers Biosciences (NASDAQ: AKER ) +42% on exploring potential business combinations in alternative sectors including cannabis industry. More news on: Akers Biosciences Inc., Leju Holdings Limited, Sphere 3D Corp., Stocks on the move, , Top stock market news, Read more … read more...
NVIDIA , Gogo, PG&E and Sphere 3D among midday movers
via: SeekingAlpha at 2018-11-16 12:46:49:000
More news on: PG&E Corporation, Sphere 3D Corp., EMC Insurance Group, Inc., Stocks on the move, , Read more … read more...
NVIDIA , Gogo, PG&E and Sphere 3D among midday movers
via: SeekingAlpha at 2018-11-16 12:46:49:000
More news on: PG&E Corporation, Sphere 3D Corp., EMC Insurance Group, Inc., Stocks on the move, , Read more … read more...
NVIDIA , Gogo, PG&E and Sphere 3D among midday movers
via: SeekingAlpha at 2018-11-16 12:46:49:000
More news on: PG&E Corporation, Sphere 3D Corp., EMC Insurance Group, Inc., Stocks on the move, , Read more … read more...
Midday Gainers / Losers
via: SeekingAlpha at 2018-11-15 12:50:10:000
More news on: uniQure N.V., Smart & Final Stores, New Age Beverages Corporation, Stocks on the move, , Read more … read more...
Akers Biosciences Q3 revenues down 18%
via: SeekingAlpha at 2018-11-15 07:23:58:000
Akers Biosciences ( AKER ) Q3 results : Revenues: $0.6M (-17.6%). More news on: Akers Biosciences Inc., Healthcare stocks news, Earnings news and commentary, , Read more … read more...
Akers Biosciences misses on revenue
via: SeekingAlpha at 2018-11-15 07:04:13:000
Akers Biosciences (NASDAQ: AKER ): Q3 net loss of $3.1M. More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Healthcare and Tech tops midday movers
via: SeekingAlpha at 2018-11-12 12:41:32:000
More news on: Apptio, OPKO Health, Inc., Globus Maritime Ltd., Stocks on the move, , Read more … read more...
Healthcare and Tech tops midday movers
via: SeekingAlpha at 2018-11-12 12:41:32:000
More news on: Apptio, OPKO Health, Inc., Globus Maritime Ltd., Stocks on the move, , Read more … read more...
Healthcare and Tech tops midday movers
via: SeekingAlpha at 2018-11-12 12:41:32:000
More news on: Apptio, OPKO Health, Inc., Globus Maritime Ltd., Stocks on the move, , Read more … read more...
Earnings movers dominate premarket losers list
via: SeekingAlpha at 2018-11-08 09:22:12:000
Achaogen (NASDAQ: AKAO ) -28% on Q3 earnings . More news on: Achaogen, Pyxus International, Inc., Zayo Group, Stocks on the move, , Top stock market news, Read more … read more...
Earnings movers dominate premarket losers list
via: SeekingAlpha at 2018-11-08 09:22:12:000
Achaogen (NASDAQ: AKAO ) -28% on Q3 earnings . More news on: Achaogen, Pyxus International, Inc., Zayo Group, Stocks on the move, , Top stock market news, Read more … read more...
Earnings movers dominate premarket losers list
via: SeekingAlpha at 2018-11-08 09:22:12:000
Achaogen (NASDAQ: AKAO ) -28% on Q3 earnings . More news on: Achaogen, Pyxus International, Inc., Zayo Group, Stocks on the move, , Top stock market news, Read more … read more...
Akers Biosciences announces a leadership change and a strategic update
via: SeekingAlpha at 2018-10-08 06:11:44:000
Akers Biosciences (NASDAQ: AKER ) announces a leadership change, an update to the Companys business strategy, the settlement of its lawsuit with Pulse Health LLC and the resignation of its Nominated Adviser on the London Stock Exchanges AIM market. More news on: Akers Bio… read more...
Akers Biosciences announces a leadership change and a strategic update
via: SeekingAlpha at 2018-10-08 06:11:44:000
Akers Biosciences (NASDAQ: AKER ) announces a leadership change, an update to the Companys business strategy, the settlement of its lawsuit with Pulse Health LLC and the resignation of its Nominated Adviser on the London Stock Exchanges AIM market. More news on: Akers Bio… read more...
Akers Biosciences announces a leadership change and a strategic update
via: SeekingAlpha at 2018-10-08 06:11:44:000
Akers Biosciences (NASDAQ: AKER ) announces a leadership change, an update to the Companys business strategy, the settlement of its lawsuit with Pulse Health LLC and the resignation of its Nominated Adviser on the London Stock Exchanges AIM market. More news on: Akers Bio… read more...
Akers Biosciences reports Q2 results
via: SeekingAlpha at 2018-08-14 16:37:52:000
Akers Biosciences (NASDAQ: AKER ): Q2 Net loss of $2.07M More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports Q2 results
via: SeekingAlpha at 2018-08-14 16:37:52:000
Akers Biosciences (NASDAQ: AKER ): Q2 Net loss of $2.07M More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports Q2 results
via: SeekingAlpha at 2018-08-14 16:37:52:000
Akers Biosciences (NASDAQ: AKER ): Q2 Net loss of $2.07M More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
AKER AUG 13 DEADLINE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First Filed Case - AKER
via: Business Wire at 2018-08-12 11:00:00:000
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akers Biosciences, Inc. (NASDAQ:AKER) from May 15, 2017 through June 5, 2018 (the Class Period) of the important August 13, 2018 lead plaintiff deadline in the first filed suit commence… read more...
AKER AUG 13 DEADLINE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First Filed Case - AKER
via: Business Wire at 2018-08-12 11:00:00:000
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Akers Biosciences, Inc. (NASDAQ:AKER) from May 15, 2017 through June 5, 2018 (the Class Period) of the important August 13, 2018 lead plaintiff deadline in the first filed suit commence… read more...
The Law Offices of Howard G. Smith Reminds Investors of August 13th Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER)
via: Business Wire at 2018-08-10 19:42:00:000
Law Offices of Howard G. Smithreminds investors of the August 13, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Akers Biosciences, Inc.(Akers or the Company) (NASDAQ: AKER… read more...
The Law Offices of Howard G. Smith Reminds Investors of August 13th Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER)
via: Business Wire at 2018-08-10 19:42:00:000
Law Offices of Howard G. Smithreminds investors of the August 13, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Akers Biosciences, Inc.(Akers or the Company) (NASDAQ: AKER… read more...
August 13th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER)
via: Business Wire at 2018-08-09 17:20:00:000
National securities litigation law firm Glancy Prongay & Murray LLP (GPM)reminds investors of the August 13, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Akers Biosciences, Inc.(… read more...
August 13th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER)
via: Business Wire at 2018-08-09 17:20:00:000
National securities litigation law firm Glancy Prongay & Murray LLP (GPM)reminds investors of the August 13, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Akers Biosciences, Inc.(… read more...
August 13th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER)
via: Business Wire at 2018-08-09 17:20:00:000
National securities litigation law firm Glancy Prongay & Murray LLP (GPM)reminds investors of the August 13, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Akers Biosciences, Inc.(… read more...
Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akers Biosciences, Inc. Investors
via: Business Wire at 2018-08-08 19:11:00:000
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Akers Biosciences, Inc. (Akers or the Company) (NASDAQ: AKER ) securities between May 15, 2017 through June 5, 2018 ,inc… read more...
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
via: Business Wire at 2018-08-08 15:52:00:000
The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akers Biosciences, Inc. (Akers or ''the Company'') (NASDAQ: AKER ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 193… read more...
AKERS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akers Biosciences, Inc. To Contact The Firm
via: PR Newswire at 2018-08-03 16:23:00:000
NEW YORK , Aug. 3, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) of the August 13, 2018 deadline to seek the role of lead plaintiff in a federal securitie… read more...
AKERS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akers Biosciences, Inc. To Contact The Firm
via: PR Newswire at 2018-08-03 16:23:00:000
NEW YORK , Aug. 3, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) of the August 13, 2018 deadline to seek the role of lead plaintiff in a federal securitie… read more...
AKERS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akers Biosciences, Inc. To Contact The Firm
via: PR Newswire at 2018-08-03 16:23:00:000
NEW YORK , Aug. 3, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) of the August 13, 2018 deadline to seek the role of lead plaintiff in a federal securitie… read more...
AKERS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akers Biosciences, Inc. To Contact The Firm
via: PR Newswire at 2018-08-03 16:23:00:000
NEW YORK , Aug. 3, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) of the August 13, 2018 deadline to seek the role of lead plaintiff in a federal securitie… read more...
AKERS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akers Biosciences, Inc. To Contact The Firm
via: PR Newswire at 2018-08-03 16:23:00:000
NEW YORK , Aug. 3, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) of the August 13, 2018 deadline to seek the role of lead plaintiff in a federal securitie… read more...
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
via: Business Wire at 2018-08-02 20:03:00:000
National Shareholder Rights Law Firm Glancy Prongay & Murray LLP (GPM) announces that it has commenced an investigation on behalf of Akers Biosciences, Inc.(Akers or the Company) (NASDAQ: AKER ) investors concerning the Company and… read more...
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
via: Business Wire at 2018-08-02 20:03:00:000
National Shareholder Rights Law Firm Glancy Prongay & Murray LLP (GPM) announces that it has commenced an investigation on behalf of Akers Biosciences, Inc.(Akers or the Company) (NASDAQ: AKER ) investors concerning the Company and… read more...
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
via: Business Wire at 2018-08-02 20:03:00:000
National Shareholder Rights Law Firm Glancy Prongay & Murray LLP (GPM) announces that it has commenced an investigation on behalf of Akers Biosciences, Inc.(Akers or the Company) (NASDAQ: AKER ) investors concerning the Company and… read more...
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
via: Business Wire at 2018-08-02 20:03:00:000
National Shareholder Rights Law Firm Glancy Prongay & Murray LLP (GPM) announces that it has commenced an investigation on behalf of Akers Biosciences, Inc.(Akers or the Company) (NASDAQ: AKER ) investors concerning the Company and… read more...
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
via: Business Wire at 2018-08-02 20:03:00:000
National Shareholder Rights Law Firm Glancy Prongay & Murray LLP (GPM) announces that it has commenced an investigation on behalf of Akers Biosciences, Inc.(Akers or the Company) (NASDAQ: AKER ) investors concerning the Company and… read more...
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
via: Business Wire at 2018-08-02 20:03:00:000
National Shareholder Rights Law Firm Glancy Prongay & Murray LLP (GPM) announces that it has commenced an investigation on behalf of Akers Biosciences, Inc.(Akers or the Company) (NASDAQ: AKER ) investors concerning the Company and… read more...
Lifshitz & Miller LLP Announces Investigation of Ankers Biosciences, Inc., Cotiviti Holdings, Inc., Energy XXI Gulf Coast, Inc., Enterprise Bank N.J., First Connecticut Bancorp, Inc., QUALCOMM Incorporated, Rent-A-Center, Inc., and Web.com Group, Inc.
via: PR Newswire at 2018-08-02 12:37:00:000
NEW YORK , Aug. 2, 2018 /PRNewswire/ -- Ankers Biosciences, Inc. (AKER) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations of improper recognition of revenue for the fiscal year ended December 31, 2017 . If… read more...
NOTICE: Rosen Law Firm Announces First Filed Securities Class Action Lawsuit on behalf of Akers Biosciences, Inc. Investors; Important August Deadline - AKER
via: Business Wire at 2018-07-30 16:36:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
NOTICE: Rosen Law Firm Announces First Filed Securities Class Action Lawsuit on behalf of Akers Biosciences, Inc. Investors; Important August Deadline - AKER
via: Business Wire at 2018-07-30 16:36:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
NOTICE: Rosen Law Firm Announces First Filed Securities Class Action Lawsuit on behalf of Akers Biosciences, Inc. Investors; Important August Deadline - AKER
via: Business Wire at 2018-07-30 16:36:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
Akers Biosciences inks deal with Appleton Medical Services for heparin PF4 rapid test covering additional 12 states
via: SeekingAlpha at 2018-07-18 07:24:34:000
Akers Biosciences (NASDAQ: AKER ) announces agreement with Appleton Medical Services, based inSt. Louis, Missouri, adding sales and marketing coverage for the Companys rapid test for heparin-induced thrombocytopenia (HIT) across an additional 12 states. More news on: Akers … read more...
Akers Biosciences inks deal with Appleton Medical Services for heparin PF4 rapid test covering additional 12 states
via: SeekingAlpha at 2018-07-18 07:24:34:000
Akers Biosciences (NASDAQ: AKER ) announces agreement with Appleton Medical Services, based inSt. Louis, Missouri, adding sales and marketing coverage for the Companys rapid test for heparin-induced thrombocytopenia (HIT) across an additional 12 states. More news on: Akers … read more...
Akers Biosciences inks deal with Appleton Medical Services for heparin PF4 rapid test covering additional 12 states
via: SeekingAlpha at 2018-07-18 07:24:34:000
Akers Biosciences (NASDAQ: AKER ) announces agreement with Appleton Medical Services, based inSt. Louis, Missouri, adding sales and marketing coverage for the Companys rapid test for heparin-induced thrombocytopenia (HIT) across an additional 12 states. More news on: Akers … read more...
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Akers Biosciences, Inc. to Contact the Firm
via: Business Wire at 2018-07-18 07:18:00:000
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc. (Nasdaq: AKER) (Akers… read more...
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Akers Biosciences, Inc. to Contact the Firm
via: Business Wire at 2018-07-18 07:18:00:000
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc. (Nasdaq: AKER) (Akers… read more...
DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Those Who Have Losses in Excess of $100,000 from Investment in Akers Biosciences, Inc. to Contact the Firm
via: Business Wire at 2018-07-18 07:18:00:000
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc. (Nasdaq: AKER) (Akers… read more...
Akers Biosciences reports Q1 results
via: SeekingAlpha at 2018-07-16 05:40:52:000
Akers Biosciences (NASDAQ: AKER ): Q1 EPS of -$0.03 More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports Q1 results
via: SeekingAlpha at 2018-07-16 05:40:52:000
Akers Biosciences (NASDAQ: AKER ): Q1 EPS of -$0.03 More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
EQUITY NOTICE: Rosen Law Firm Announces First Filed Securities Class Action Lawsuit on behalf of Akers Biosciences, Inc. Investors; Important Deadline - AKER
via: PR Newswire at 2018-07-15 13:00:00:000
NEW YORK , July 15, 2018 /PRNewswire-USNewswire/ --Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 … read more...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- AKER
via: PR Newswire at 2018-07-07 08:00:00:000
NEW YORK , July 7, 2018 /PRNewswire/ --Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) and certain of its officers. The class action, filed in United States District Court, Dis… read more...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- AKER
via: PR Newswire at 2018-07-07 08:00:00:000
NEW YORK , July 7, 2018 /PRNewswire/ --Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) and certain of its officers. The class action, filed in United States District Court, Dis… read more...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- AKER
via: PR Newswire at 2018-07-07 08:00:00:000
NEW YORK , July 7, 2018 /PRNewswire/ --Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) and certain of its officers. The class action, filed in United States District Court, Dis… read more...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline -- AKER
via: PR Newswire at 2018-07-07 08:00:00:000
NEW YORK , July 7, 2018 /PRNewswire/ --Pomerantz LLP announces that a class action lawsuit has been filed against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) and certain of its officers. The class action, filed in United States District Court, Dis… read more...
AKER LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
via: Business Wire at 2018-07-03 14:47:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
AKER LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
via: Business Wire at 2018-07-03 14:47:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
AKER LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
via: Business Wire at 2018-07-03 14:47:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
AKER LOSS NOTICE: Rosen Law Firm Files Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
via: Business Wire at 2018-07-03 14:47:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
Akers Biosciences further extends outsourced US distribution capabilities for Heparin PF4 rapid test
via: SeekingAlpha at 2018-07-03 07:30:21:000
Akers Biosciences (NASDAQ: AKER ) announced agreements with Stone Mountain Surgical, Aspen Scientific, Evolution Surgical, ACT Medical, BCD Medical and Tuzik Boston to further expand US sales and marketing capabilities for the Companys rapid test for heparin-induced thrombocytopenia … read more...
Akers Biosciences further extends outsourced US distribution capabilities for Heparin PF4 rapid test
via: SeekingAlpha at 2018-07-03 07:30:21:000
Akers Biosciences (NASDAQ: AKER ) announced agreements with Stone Mountain Surgical, Aspen Scientific, Evolution Surgical, ACT Medical, BCD Medical and Tuzik Boston to further expand US sales and marketing capabilities for the Companys rapid test for heparin-induced thrombocytopenia … read more...
Akers Biosciences further extends outsourced US distribution capabilities for Heparin PF4 rapid test
via: SeekingAlpha at 2018-07-03 07:30:21:000
Akers Biosciences (NASDAQ: AKER ) announced agreements with Stone Mountain Surgical, Aspen Scientific, Evolution Surgical, ACT Medical, BCD Medical and Tuzik Boston to further expand US sales and marketing capabilities for the Companys rapid test for heparin-induced thrombocytopenia … read more...
Akers Biosciences further extends outsourced US distribution capabilities for Heparin PF4 rapid test
via: SeekingAlpha at 2018-07-03 07:30:21:000
Akers Biosciences (NASDAQ: AKER ) announced agreements with Stone Mountain Surgical, Aspen Scientific, Evolution Surgical, ACT Medical, BCD Medical and Tuzik Boston to further expand US sales and marketing capabilities for the Companys rapid test for heparin-induced thrombocytopenia … read more...
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Akers Biosciences, Inc. to Contact the Firm
via: Business Wire at 2018-06-29 17:52:00:000
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. (Akers Biosciences or the Company) (NASDAQ:AKER). If you invested in Akers stock or options and would like to discuss your… read more...
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Akers Biosciences, Inc. to Contact the Firm
via: Business Wire at 2018-06-29 17:52:00:000
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. (Akers Biosciences or the Company) (NASDAQ:AKER). If you invested in Akers stock or options and would like to discuss your… read more...
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Akers Biosciences, Inc. to Contact the Firm
via: Business Wire at 2018-06-29 17:52:00:000
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. (Akers Biosciences or the Company) (NASDAQ:AKER). If you invested in Akers stock or options and would like to discuss your… read more...
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Akers Biosciences, Inc. to Contact the Firm
via: Business Wire at 2018-06-29 17:52:00:000
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. (Akers Biosciences or the Company) (NASDAQ:AKER). If you invested in Akers stock or options and would like to discuss your… read more...
Akers Biosciences requests temporary suspension of trading on London Stock Exchange
via: SeekingAlpha at 2018-06-29 08:04:00:000
Akers Biosciences (NASDAQ: AKER ) request London Stock Exchange to suspend trading on the AIM Market with effect from 7.30 a.m. BST on July 2, 2018 pending publication of revised annual audited accounts for 2017. More news on: Akers Biosciences Inc., Healthcare stocks news, Read more …. read more...
Akers Biosciences requests temporary suspension of trading on London Stock Exchange
via: SeekingAlpha at 2018-06-29 08:04:00:000
Akers Biosciences (NASDAQ: AKER ) request London Stock Exchange to suspend trading on the AIM Market with effect from 7.30 a.m. BST on July 2, 2018 pending publication of revised annual audited accounts for 2017. More news on: Akers Biosciences Inc., Healthcare stocks news, Read more …. read more...
Akers Biosciences requests temporary suspension of trading on London Stock Exchange
via: SeekingAlpha at 2018-06-29 08:04:00:000
Akers Biosciences (NASDAQ: AKER ) request London Stock Exchange to suspend trading on the AIM Market with effect from 7.30 a.m. BST on July 2, 2018 pending publication of revised annual audited accounts for 2017. More news on: Akers Biosciences Inc., Healthcare stocks news, Read more …. read more...
Akers Biosciences requests temporary suspension of trading on London Stock Exchange
via: SeekingAlpha at 2018-06-29 08:04:00:000
Akers Biosciences (NASDAQ: AKER ) request London Stock Exchange to suspend trading on the AIM Market with effect from 7.30 a.m. BST on July 2, 2018 pending publication of revised annual audited accounts for 2017. More news on: Akers Biosciences Inc., Healthcare stocks news, Read more …. read more...
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Akers Biosciences, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit
via: Business Wire at 2018-06-28 06:28:00:000
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Akers Biosciences, Inc. (Nasdaq: AKER) (Akers… read more...
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
via: Business Wire at 2018-06-25 16:52:00:000
The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akers Biosciences, Inc. (Akers or the Company) (NASDAQ: AKER ) for violations of 10(b) and 20(a) of the Securities Exchang… read more...
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
via: Business Wire at 2018-06-25 16:52:00:000
The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akers Biosciences, Inc. (Akers or the Company) (NASDAQ: AKER ) for violations of 10(b) and 20(a) of the Securities Exchang… read more...
INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
via: Business Wire at 2018-06-25 16:52:00:000
The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Akers Biosciences, Inc. (Akers or the Company) (NASDAQ: AKER ) for violations of 10(b) and 20(a) of the Securities Exchang… read more...
AKER LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
via: Business Wire at 2018-06-19 16:55:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
AKER LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
via: Business Wire at 2018-06-19 16:55:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
AKER LOSS NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Akers Biosciences, Inc. - AKER
via: Business Wire at 2018-06-19 16:55:00:000
Rosen Law Firm, a global investor rights law firm, announces it has filed the first class action lawsuit on behalf of purchasers of the securities of Akers Biosciences, Inc. (NASDAQ: AKER) from May 15, 2017 through June 5, 2018 (the Class Period). The lawsuit seeks to recover… read more...
Robbins Arroyo LLP: Akers Biosciences, Inc. (AKER) Misled Shareholders According to a Recently Filed Class Action
via: Business Wire at 2018-06-18 16:58:00:000
Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of Akers Biosciences, Inc. (NasdaqCM: AKER) have filed a class action complaint against the company's officers and directors for alleged violations of the Securities Exchange Act of 1934 between May 15, 2017 and June … read more...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
via: Business Wire at 2018-06-15 18:57:00:000
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1… read more...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
via: Business Wire at 2018-06-15 18:57:00:000
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1… read more...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
via: Business Wire at 2018-06-15 18:57:00:000
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1… read more...
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm
via: PR Newswire at 2018-06-15 18:27:00:000
NEW YORK , June 15, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). If you invested in Akers stock or options and would like to disc… read more...
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm
via: PR Newswire at 2018-06-15 18:27:00:000
NEW YORK , June 15, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). If you invested in Akers stock or options and would like to disc… read more...
AKERS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Akers Biosciences, Inc. To Contact The Firm
via: PR Newswire at 2018-06-15 18:27:00:000
NEW YORK , June 15, 2018 /PRNewswire/ --Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). If you invested in Akers stock or options and would like to disc… read more...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akers Biosciences, Inc. - AKER
via: PR Newswire at 2018-06-15 13:50:00:000
NEW YORK , June 15, 2018 /PRNewswire/ --Pomerantz LLP is investigating claims on behalf of investors ofAkers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ:AKER).Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com o… read more...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akers Biosciences, Inc. - AKER
via: PR Newswire at 2018-06-15 13:50:00:000
NEW YORK , June 15, 2018 /PRNewswire/ --Pomerantz LLP is investigating claims on behalf of investors ofAkers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ:AKER).Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com o… read more...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Akers Biosciences, Inc. - AKER
via: PR Newswire at 2018-06-15 13:50:00:000
NEW YORK , June 15, 2018 /PRNewswire/ --Pomerantz LLP is investigating claims on behalf of investors ofAkers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ:AKER).Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com o… read more...
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline - August 13, 2018
via: PR Newswire at 2018-06-14 10:15:00:000
NEW YORK , June 14, 2018 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) and certain of its officers, on behalf of shareho… read more...
Akers Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Akers Biosciences, Inc. - AKER
via: PR Newswire at 2018-06-13 16:46:00:000
NEW YORK , June 13, 2018 /PRNewswire/ -- Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER) between May 15, 2017 and June… read more...
Bragar Eagel & Squire, P.C. is Investigating Akers Biosciences, Inc. (AKER) on Behalf of Stockholders and Encourages Investors to Contact the Firm
via: Business Wire at 2018-06-13 15:56:00:000
Bragar Eagel & Squire, P.C. is investigating potential claims against Akers Biosciences, Inc. (NASDAQ: AKER). Our investigation concerns whether Akers Biosciences has violated the federal securities laws and/or engaged in other unlawful business practices. On May 21, 2018, Akers reve… read more...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Akers Biosciences, Inc. Investors (AKER)
via: Business Wire at 2018-06-13 15:05:00:000
Law Offices of Howard G. Smithannounces an investigation on behalf of Akers Biosciences, Inc. (Akers or the Company) (NASDAQ: AKER ) investors concerning the Company and its officers possible violations of federal securities laws. On Ma… read more...
NEW INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
via: Business Wire at 2018-06-13 13:10:00:000
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1… read more...
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Akers Biosciences, Inc. (AKER)
via: PR Newswire at 2018-06-13 12:39:00:000
NEW YORK , June 13, 2018 /PRNewswire/ --Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). Such investors are encouraged to obtain additional i… read more...
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Akers Biosciences, Inc. - AKER
via: Business Wire at 2018-06-13 09:39:00:000
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Akers Biosciences, Inc. (NASDAQ: AKER) resulting from allegations that Akers may have issued materially misleading business information to the investing p… read more...
Akers Shareholders: Bernstein Liebhard LLP Announces Investigation Of Akers Biosciences, Inc. - AKER
via: PR Newswire at 2018-06-13 09:30:00:000
NEW YORK , June 13, 2018 /PRNewswire/ --Bernstein Liebhard LLP is investigating potential securities fraud claims on behalf of shareholders of Akers Biosciences, Inc. ("Akers" or the "Company") (NASDAQ: AKER). If you purchased Akers securities, and/or have information relating to th… read more...
Akers Biosciences (AKER) CEO John Gormally on Q4 2017 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-04-03 15:37:05:000
Executives John Gormally - Chief Executive Officer Gary Rauch - VP of Finance Ben Simons - Corporate Communications Analysts James Terwilliger - Paulson Investment Co. Marc Robin - Catalyst Research Michael Clark - Private Investor Presentation Operator Good morning… read more...
Akers Biosciences (AKER) CEO John Gormally on Q4 2017 Results - Earnings Call Transcript
via: SeekingAlpha at 2018-04-03 15:37:05:000
Executives John Gormally - Chief Executive Officer Gary Rauch - VP of Finance Ben Simons - Corporate Communications Analysts James Terwilliger - Paulson Investment Co. Marc Robin - Catalyst Research Michael Clark - Private Investor Presentation Operator Good morning… read more...
Akers Biosciences down 15% premarket on FY 2017 results
via: SeekingAlpha at 2018-04-03 07:14:02:000
Akers Biosciences ( AKER ) FY results : Revenues: $3.9M (+30.0%); Operating Loss: ($5.1M) (-54.5%); Net Loss: ($5.8M) (-75.8%); Loss Per Share: ($0.61) (unch); Quick Assets: $5.5M; CF Ops: ($5.1M) (-21.4%). More news on: Akers Biosciences Inc., Healthcare stocks news, Earnings news and co… read more...
Akers Biosciences down 15% premarket on FY 2017 results
via: SeekingAlpha at 2018-04-03 07:14:02:000
Akers Biosciences ( AKER ) FY results : Revenues: $3.9M (+30.0%); Operating Loss: ($5.1M) (-54.5%); Net Loss: ($5.8M) (-75.8%); Loss Per Share: ($0.61) (unch); Quick Assets: $5.5M; CF Ops: ($5.1M) (-21.4%). More news on: Akers Biosciences Inc., Healthcare stocks news, Earnings news and co… read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2018-04-03 07:05:24:000
Akers Biosciences (NASDAQ: AKER ): FY net loss of $5.8M More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences reports FY results
via: SeekingAlpha at 2018-04-03 07:05:24:000
Akers Biosciences (NASDAQ: AKER ): FY net loss of $5.8M More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences signs US distribution agreement with Diagnostica Stago; shares ahead 14% premarket
via: SeekingAlpha at 2018-03-26 08:31:17:000
Akers Biosciences (NASDAQ: AKER ) has entered into a three-year National Distribution Agreement with Diagnostica Stago, Inc. for the sale of its rapid test for Heparin-induced thrombocytopenia (HIT) in the US. More news on: Akers Biosciences Inc., Healthcare stocks news, … read more...
Akers Biosciences signs US distribution agreement with Diagnostica Stago; shares ahead 14% premarket
via: SeekingAlpha at 2018-03-26 08:31:17:000
Akers Biosciences (NASDAQ: AKER ) has entered into a three-year National Distribution Agreement with Diagnostica Stago, Inc. for the sale of its rapid test for Heparin-induced thrombocytopenia (HIT) in the US. More news on: Akers Biosciences Inc., Healthcare stocks news, … read more...
2017 YTD worst losers - healthcare
via: SeekingAlpha at 2017-12-22 11:00:14:000
Reminding investors of tears shed and fortunes lost, here are the top losers in healthcare this year: More news on: CHF Solutions, Inc., Argos Therapeutics, Inc., Dextera Surgical Inc., Healthcare stocks news, Read more … read more...
Akers' equity offering sinks shares, down 61%
via: SeekingAlpha at 2017-12-19 10:56:42:000
Thinly traded nano cap Akers Biosciences ( AKER -61.4% ) slumps on a 23x surge in volume in response to its $6M public equity offering . More news on: Akers Biosciences Inc., Healthcare stocks news, Stocks on the move, Read more … read more...
Akers Biosciences' (AKER) CEO John Gormally on Q3 2017 Results - Earnings Call Transcript
via: SeekingAlpha at 2017-11-15 14:11:09:000
Akers Biosciences, Inc. (AKER) Q3 2017 Results Conference Call November 15, 2017 09:00 AM ET Executives Ben Simons - Global Public Relations Manager, Vigo Communications John Gormally - CEO Dr. Ray Akers - Executive Chairman & Chief Scientific Director Gary Rauch - VP, Fina… read more...
Akers Biosciences reports Q3 results
via: SeekingAlpha at 2017-11-15 07:04:55:000
Akers Biosciences (NASDAQ: AKER ): Q3 EPS of -$0.13 More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Midday Gainers / Losers
via: SeekingAlpha at 2017-10-16 12:43:36:000
Gainers: RCON +106% . TRXC +71% . LBIX +30% . EXEL +25% . RT +19% . SNES +18% . LINU +15% . DTRM +14% . HIIQ +13% . SIFY +13% . More news on: Recon Technology, Ltd., TransEnterix, Inc., Leading Brands Inc, Stocks on the move, Read more … read more...
Midday Gainers / Losers
via: SeekingAlpha at 2017-10-13 12:45:09:000
Gainers: LBIX +153% . NETE +43% . CDTI +32% . MARK +22% . SOHU +14% . FRSX +14% . SPAR +13% . ALBO +12% . PN +11% . ZN +10% . More news on: Leading Brands Inc, Net Element International, Inc., Clean Diesel Technologies, Inc., Stocks on the move, Read mo… read more...
Premarket Gainers as of 9:05 am
via: SeekingAlpha at 2017-10-13 09:17:57:000
MARK +39% . More news on: Remark Media, Inc., Inotek Pharmaceuticals, Miragen Therapeutics, Inc., Stocks on the move, Read more … read more...
Akers Biosciences' (AKER) CEO John Gormally on Q2 2017 Results - Earnings Call Transcript
via: SeekingAlpha at 2017-08-15 13:22:03:000
Start Time: 09:00 End Time: 09:27 Akers Biosciences, Inc. (AKER) Q2 2017 Earnings Conference Call August 15, 2017, 09:00 AM ET Executives John Gormally - CEO Ray Akers - Vice Chairman Gary Rauch - VP, Finance Ben Simons - Global Public Relations Manager, Vigo Communications… read more...
Akers Biosciences reports Q2 results
via: SeekingAlpha at 2017-08-15 05:45:48:000
Akers Biosciences (NASDAQ: AKER ): Q2 EPS of -$0.08 More news on: Akers Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Akers Biosciences' (AKER) CEO John Gormally on Q1 2017 Results - Earnings Call Transcript
via: SeekingAlpha at 2017-05-16 12:21:26:000
Akers Biosciences Inc. (AKER) Q1 2017 Earnings Conference Call May 16, 2017 09:00 AM ET Executives Fiona Henson - Global Public Relations Manager, Vigo Communications John Gormally - Chief Executive Officer Ray Akers - Vice Chairman Gary Rauch - Vice President, Finance Analy… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|